Mats Christer Henriksson

Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany.

Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India.

Fresenius Kabi Austria GmbH develops and distributes IV drugs and nutrition products. It specializes in infusion and nutrition therapy. The firm offers active pharmaceutical ingredients, infusion therapy, oncology drugs, parenteral nutrition, enteral nutrition, medical devices, and hesylation. The company was founded in 1997 and is headquartered in Graz, Austria.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi España SA is a company based in Barcelona, Spain that develops and produces drugs and medical devices for critical care therapies with chronic diseases worldwide. The Spanish company offers a wide range of products, including substitution of blood volume, critical disease, diabetes mellitus, liquid management, hepatic insufficiency, digestive problems/absorption, nutritional support, pediatrics, renal insufficiency, enteral nutrition, nasogastric probe food, oral nutritional supplements, anesthetic, generic medicines/antibiotic, analgesic, oncology, and other fluid therapy infion medical irrigation devices. Fresenius Kabi is committed to putting essential medicines and technologies in the hands of people who help patients and find the best responses to the challenges they face.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Japan KK is a leading Japanese company for infusion therapy, nutrition therapy, and blood transfusion technology products. The company is based in Tokyo, Japan. The company provides drugs and medical equipment to patients with severe chronic diseases, which are indispensable in acute care and used to treat patients at the hospital and home.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Fresenius Kabi Italia Srl specializes in drugs and technologies for infusion, transfusion and clinical nutrition. The firm’s products include autologous, colloids, biosimilars, enteral nutrition, and infusion therapy. The company is headquartered in Isola della Scala, Italy.

Part of Fresenius SE & Co. KGaA, Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is a company that manufactures infusion solutions for volume therapy and standard infusion solutions. Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Fresenius Kabi Pharmaceutical Co. was acquired by Fresenius Kabi AG on April 05, 2005 for $30.21 million.